5Krassas GE,Kahaly GJ.The role of octreoscan in thyroid eye disease[J].Eur J Endocrinol,1999,140(5):373-375.
6Nocaudie M,Bailliez A,Itti E,et al.Somatastatin receptor scintigraphy to predict the clinical evolution and theraputic response of thyroid associated ophthalmopathy[J].Eur J Nucl Med,1999,26(5):511-517.
7Colao A,Lastoria S,Ferone D,et al.Orbital scintigraphy with [111In-diethylenetriamine pantaacetic acid-D-Phe]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy[J].J Clin Endocrinol Metab,1998,83(11):3790-3794.
8Krassas GE,Dumas A,Pontikides N,et al.Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease[J],Clin Endocrinol,1995,42(6):571.
9Gerding MN,van-der-Zant FM,van Royen EA,et al.Octreotide scintigraphy is a disease activity parameter in Graves' ophthalmopathy[J].Clin Endocrinol Oxf,1999,50(3):373-379.
10Gray E, Gavel JP, Thuillier A, et al. Lipid peroxidation and free radicals role in cellular biology and pathology. Pathology Pathol Biol 1985; 37: 24
1Gorbenko MV,Popova TN, Shul'gin KK, et al. Effect of melaxen and valdoxan on free radical processes intensity, aeonitate hydratase activity and citrate content in rats tissues under hy- perthyroidism[J].Biorned Khim, 2014,60 (4) :462-468.
2Robinson MV, Obut TA, Melnikova EV, et al. Parameters of cellular and humoral immunity in experimental hyperthyroidism BiolMed,2014,156(4):473.
